← Leaderboards
Christina Allen Rostad
University Of California, San Francisco
$1,610,116
Attributed
$6,440,465
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.2M · FY2021–23$5M$3.8M$2.5M$1.3M$0
'21
'22
'23
Funding mix
By agency
NIH$6,440,465 · 2
By mechanism
R33$3,225,866 · 1
R61$3,214,599 · 1
Top collaborators
- Charles Yen Chiu5 shared
- Roberta Lynn Debiasi5 shared
- Iwijn De Vlaminck5 shared
Most similar at University Of California, San Francisco
Same institution · by research overlap
- Charles Yen Chiu$12,010,203
- Steven C Hall$1,704,397
- Mary Prahl$3,066,454
- Luisa N Borrell$2,014,697
- Jose Rodriguez-Santana$3,544,948
Others in their field
Other Emerging Leaders on “Hospitals”
- Beth Baseler · Leidos Biomedical Research, Inc.$105,136,677
- Ted Ross · University Of Georgia$68,763,143
- Abraham Aizer Brody · New York University School Of Medicine$40,089,349
- Xinhua Li · Nano Terra, Inc.$32,991,103
- James Dale Berry · Brigham And Women'S Hospital$20,824,388
- Tareq Al Baghdadi · Saint Joseph Mercy Health System$19,225,531
Research focus
HospitalsNasal SwabDiagnosisGenetic PedigreeInflammatoryMultisystem Inflammatory Syndrome In ChildrenCovid-19Covid-19 SeverityDiagnosticEnrollmentCohortInfectionLaboratoriesMonitorAcuteChildhoodCovid-19 PatientCaliforniaCell Free DnaBiobankBiological MarkersDna AnalysisChildPediatric Cohort
Grant awards (5)
Discovery and clinical validation of host biomarkers of disease severity and multi-system inflammatory syndrome in children (MIS-C) with Covid-19$1,619,520
R33 · FY2023 · HD
Discovery and clinical validation of host biomarkers of disease severity and multi-system inflammatory syndrome in children (MIS-C) with Covid-19$1,606,346
R33 · FY2023 · HD
Uncovering associations of variant infection with COVID-19 disease severity in children$1,541,111
R61 · FY2022 · HD
Discovery and clinical validation of host biomarkers of disease severity and multi-system inflammatory syndrome in children (MIS-C) with Covid-19$809,678
R61 · FY2022 · HD
Discovery and clinical validation of host biomarkers of disease severity and multi-system inflammatory syndrome in children (MIS-C) with Covid-19$863,810
R61 · FY2021 · HD